1. Precision Medicine: The Potential for Identifying Personalized Therapies for Patients with Gastro-Esophageal Cancer

2. Disclosures

5. Epidemiology

6. Risk factors

7. Gastric Cancer: Histology

8. TN Staging of Gastric Cancer

10. Stage and Outcomes

11. Therapy

12. First Line Metastatic Disease

13. First Line: HER2+ Disease

14. Second Line Metastatic Disease

16. A Heterogeneous Disease

17. Four Genomic Subtypes

20. PD-1 Inhibitors

23. Molecular Profiling – An Example

24. Molecular Profiling – An Example

25. Molecular Profiling – An Example

26. Molecular Profiling – An Example

28. Perthera and the Pancreatic Cancer Action Network partner on Know Your Tumor

29. Know Your Tumor Results to Date: Enrollment

30. Tissue Availability Data

32. Actionability: Specific Results

33. Actionable Findings in Gastric Cancer?

37. Pitfalls and Concerns

38. Is Molecular Profiling Cost Effective?

39. Thank You